News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: January 9, 2025
In the PATINA trial, patients received first-line treatment of induction chemotherapy plus anti-HER2 therapy and then were randomized to either pal...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 17, 2024
Just under 500 women with DCIS were randomized to active surveillance or standard upfront surgery with or without radiation in a new trial.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: December 16, 2024
A combination of imlunestrant plus abemaciclib led to a significant improvement in progression-free survival compared with imlunestrant alone, rega...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: September 30, 2024
Research suggests that obesity can reduce the effectiveness of cancer therapies.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 17, 2022
The one-time gene therapy represents a potential cure in which functional copies of the mutated gene are inserted into patients’ hematopoietic stem...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 17, 2022
“Given that Black men are younger at diagnosis and have worse prostate cancer survival compared with White men,” more intensive screening recommend...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: August 5, 2022
Sixty percent of patients previously classified as having HER2-negative subtype are now considered HER2 low.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: June 21, 2022
The increase wasn’t enough to offset the overall benefit of vaccination when all genotypes were considered, said the researchers.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: June 8, 2022
“Commonly used medications may have a larger impact on the efficacy and toxicity of immune checkpoint blockade than historically seen with chemothe...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 26, 2021
The decision to use a biologic should hinge on how badly patients and their quality of life are affected, Dr. Langley said.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 24, 2021
As in past trials, oral candidiasis was an issue in patients taking bimekizumab.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 23, 2021
Bimekizumab “appears more effective than current options. The big question is safety.”
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 19, 2021
Phase 3 results support omitting cyclophosphamide from standard chemotherapy.
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: April 5, 2021
Data suggest liver transplant can improve survival in colorectal cancer patients with extensive hepatic metastase...
News
- Author:
- M. Alexander Otto, PA, MMS
Publish date: March 8, 2021
A taxane/platinum doublet works just as well as the standard anthracycline-containing regimen.
